Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Influenza
2021
2016
Americas
Clear all
Type of publications
NITAG documentation
(74)
Systematic reviews (SYSVAC)
(3)
Topics
Available to download in languages
Regions
Americas
(77)
Africa
(17)
Europe
(82)
South-East Asia
(2)
Western Pacific
(17)
Countries
Argentina
(1)
Bolivia
(2)
Canada
(18)
Chile
(9)
United States of America
(47)
Diseases
COVID-19
(64)
Influenza
(13)
Cholera
(3)
Dengue
(1)
Diphtheria
(4)
Ebola
(1)
Hepatitis A
(1)
Human papillomavirus (HPV)
(17)
Japanese encephalitis
(2)
Meningococcal disease
(10)
Pneumococcal disease
(1)
Poliomyelitis
(1)
Rotavirus
(5)
Smallpox
(2)
Vaccine topics
Acceptance
(1)
Coverage
(1)
Ethical issues
(2)
Target population
Adults
(2)
All age groups
(2)
Children
(3)
Healthcare workers
(1)
Older adults
(1)
Parents/caregivers
(1)
Pregnant women
(4)
Publication date
2021
(64)
2016
(13)
2024
(2)
2023
(12)
2022
(48)
2020
(66)
2019
(6)
2018
(7)
2017
(3)
2015
(8)
2014
(9)
2013
(1)
2012
(3)
2011
(2)
2010
(4)
2009
(6)
2008
(1)
2007
(1)
2006
(1)
77 results found
2021
∙
ACIP
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine
2021
∙
ACIP
The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine
2021
∙
ACIP
The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine
2021
∙
ACIP
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update of ACIP - 9 July 2021
2016
∙
NACI
ADDENDUM - LAIV Use in Children and Adolescents
2016
∙
NACI
ADDENDUM - LAIV Use in Egg Allergic Individuals Advisory Committee Statement (ACS)
2016
∙
ACIP
Prevention and Control of Seasonal Influenza with Vaccines
2016
∙
Chris Ambrose
2015-16 US Influenza Vaccine Effectiveness Influenza Clinical Investigation for Children (ICICLE) Study
2016
∙
Tom Shimabukuro
End-of-Season Update: 2015-2016 Influenza Vaccine Safety Monitoring
2016
∙
J Mansi
FLUCELVAX QUADRIVALENT® (Influenza Vaccine) – ccIIV4
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register